Journal of Acute Care

Register      Login

VOLUME 2 , ISSUE 1 ( January-April, 2023 ) > List of Articles


Role of Statin and Clinical Outcomes in COVID-19 Patients: A Protocol for Systematic Review and Meta-analysis of Randomized Controlled Trials

Khushboo Saran, Sharmili Sinha, Shio Priye

Keywords : Coronavirus disease 2019, Outcome, Statin

Citation Information : Saran K, Sinha S, Priye S. Role of Statin and Clinical Outcomes in COVID-19 Patients: A Protocol for Systematic Review and Meta-analysis of Randomized Controlled Trials. 2023; 2 (1):38-41.

DOI: 10.5005/jp-journals-10089-0038

License: CC BY-NC 4.0

Published Online: 23-08-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Objectives: Statins have significant therapeutic implications in patients having high cardiovascular risk or preexisting cardiovascular disorders. Exploring the correlation between statin therapy and outcomes in coronavirus disease 2019 (COVID-19) patients is the objective of the current meta-analysis. Data sources: PubMed, Web of Science, Google Scholar, and Cochrane Library database, as well as preprint services like medRxiv, Research Square, and Social Science Research Network (SSRN). Study selection: All citations will be double-checked, and any differences will be examined and, if required, addressed with the help of a third author. Two authors will separately evaluate abstracts and titles of all potentially essential citations in two phases. Data extraction: A data extraction table will be used to extract published outcomes from each study. Data synthesis: The pooled risk ratio with a 95% confidence interval (CI) will be used to compute pooled effect size. DerSimonian and Laird random-effects models will be employed for heterogeneity greater than 50%; otherwise, the fixed-effects model will be implemented. To construct study weights, an inverse variance approach will be employed, and a funnel plot will also be examined to see whether there is any publishing bias. Trial registry: International prospective register of systematic reviews (Prospero) acquired a prospective registration for this meta-analysis in the trial registry (CRD42022304331). Study highlights: The evidence supporting the use of statins in COVID-19 patients will be reviewed in this study. Early statin has been correlated to a decreased risk of unfavorable effects in patients with COVID-19. At the time, these trials were predominantly observational, and all published meta-analyses were based on observational studies. Randomized controlled trials have recently been performed for reliable evidence, but no meta-analyses.

  1. Bhattacharya PK, Prakash J. Impact of COVID-19 on psychological and emotional well-being of healthcare workers. Indian J Crit Care Med 2021;25(5):479–481. DOI: 10.5005/jp-journals-10071-23833
  2. Prakash J, Bhattacharya PK, Priye S, et al. Post-COVID-19 pulmonary fibrosis: a lifesaving challenge. Indian J Crit Care Med 2021;25(1):104–105. DOI: 10.5005/jp-journals-10071-23709
  3. Kow CS, Hasan SS. Meta-analysis of effect of statins in patients with COVID-19. Am J Cardiol 2020;134:153–155. DOI: 10.1016/j.amjcard.2020.08.004
  4. Sahebkar A, Serban C, Mikhailidis DP, et al. Association between statin use and plasma d-dimer levels: a systematic review and meta-analysis of randomized controlled trials. ThrombHaemost 2015;114(3):546–557. DOI: 10.1160/TH14-11-0937
  5. Pal R, Banerjee M, Yadav U, et al. Statin use and clinical outcomes in patients with COVID-19: an updated systematic review and meta-analysis. Postgrad Med J 2022;98(1159):354–359. DOI: 10.1136/postgradmedj-2020-139172
  6. Ganjali S, Bianconi V, Penson PE, et al. Commentary: statins, COVID-19, and coronary artery disease: killing two birds with one stone. Metabolism 2020;113:154375. DOI: 10.1016/j.metabol.2020.154375
  7. Castiglione V, Chiriacò M, Emdin M, et al. Statin therapy in COVID-19 infection. Eur Heart J Cardiovasc Pharmacother 2020;6(4):258–259. DOI: 10.1093/ehjcvp/pvaa042
  8. Kow CS, Thiruchelvam K, Hasan SS. Pharmacotherapeutic considerations for the management of cardiovascular diseases among hospitalized COVID-19 patients. Expert Rev CardiovascTher 2020;18(8):475–485. DOI: 10.1080/14779072.2020.1797492
  9. INSPIRATION-S Investigators. Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial. BMJ 2022;376:e068407. DOI: 10.1136/bmj-2021-068407
  10. Davoodi L, Jafarpour H, Oladi Z, et al. Atorvastatin therapy in COVID-19 adult inpatients: a double-blind, randomized controlled trial. Int J Cardiol Heart Vasc 2021;36:100875. DOI: 10.1016/j.ijcha.2021.100875
  11. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535. DOI: 10.1136/bmj.b2535
  12. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. Version 5.1.0.Oxford: The Cochrane Collaboration; 2011.
  13. Higgins JP, Altman DG, Gøtzsche PC, et al. Cochrane bias methods group; Cochrane statistical methods group. The Cochrane collaboration's tool for assessing risk of bias in randomized trials. BMJ 2011;343:d5928. DOI: 10.1136/bmj.d5928
  14. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21(11):1539–1558. DOI: 10.1002/sim.1186
  15. Onorato D, Pucci M, Carpene G, et al. Protective effects of statins administration in European and North American patients infected with COVID-19: a meta-analysis. Semin Thromb Hemost 2021;47(4):392–399. DOI: 10.1055/s-0040-1722307
  16. Wu KS, Lin PC, Chen YS, et al. The use of statins was associated with reduced COVID-19 mortality: a systematic review and meta-analysis. Ann Med 2021;53(1):874–884. DOI: 10.1080/07853890.2021.1933165
  17. Zhang XJ, Qin JJ, Cheng X, et al. In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19. Cell Metab 2020;32(2):176–187. DOI: 10.1016/j.cmet.2020.06.015
  18. Gupta A, Madhavan MV, Poterucha TJ, et al. Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19. Nat Commun 2021;12(1):1325. DOI: 10.1038/s41467-021-21553-1
  19. Abdulrab S, Alkadasi B, Al-Maweri S, et al. Statins-based prophylactic mouthwash and nasal spray may protect against coronavirus disease 2019. New Microbes New Infect 2020;37:100751. DOI: 10.1016/j.nmni.2020.100751
  20. Nežić L, Škrbić R, Amidžić L, et al. Simvastatin protects cardiomyocytes against endotoxin-induced apoptosis and up-regulates survivin/NF-κB/p65 expression. Sci Rep 2018;8(1):14652. DOI: 10.1038/s41598-018-32376-4
  21. Teoh N, Farrell G. Statins as early therapy to mitigate COVID-19(SARS-CoV-2)—associated ARDS and cytokine storm syndrome - time is of the essence. J Clin Transl Res 2020;5(5):227–229.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.